Bloomage Biotechnology Corp Ltd
SSE:688363

Watchlist Manager
Bloomage Biotechnology Corp Ltd Logo
Bloomage Biotechnology Corp Ltd
SSE:688363
Watchlist
Price: 50.49 CNY -2.23% Market Closed
Market Cap: 9.9B CNY
Have any thoughts about
Bloomage Biotechnology Corp Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Bloomage Biotechnology Corp Ltd stock under the Base Case scenario is 94.33 CNY. Compared to the current market price of 50.49 CNY, Bloomage Biotechnology Corp Ltd is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
94.33 CNY
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
80
vs Industry
64
Median 3Y
2.4
Median 5Y
4.1
Industry
6.8
Forward
1.7
More Details
300.4
P/E
P/E
Price to Earnings
300.4
vs History
0
vs Industry
3
Median 3Y
24.3
Median 5Y
30.5
Industry
21.9
Forward
39.5
More Details
19.4
P/OCF
P/OCF
Price to OCF
19.4
vs History
65
vs Industry
5
Median 3Y
19.9
Median 5Y
27
Industry
19.5
More Details
83.5
P/FCFE
P/FCFE
Price to FCFE
83.5
vs History
25
vs Industry
0
Median 3Y
-39.1
Median 5Y
-39.1
Industry
23.4
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
88
vs Industry
27
Median 3Y
2.1
Median 5Y
3.8
Industry
2.4
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
79
vs Industry
54
Median 3Y
2.4
Median 5Y
3.8
Industry
7.2
Forward
1.6
More Details
2.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.6
vs History
79
vs Industry
52
Median 3Y
3.2
Median 5Y
5
Industry
9.1
More Details
170.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
170.5
vs History
0
vs Industry
3
Median 3Y
20
Median 5Y
25
Industry
3.9
Forward
8.4
More Details
170.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
170.5
vs History
0
vs Industry
3
Median 3Y
20
Median 5Y
25
Industry
3.8
Forward
13.9
More Details
18.8
EV/OCF
EV/OCF
Enterprise Value to OCF
18.8
vs History
65
vs Industry
5
Median 3Y
19.2
Median 5Y
25.2
Industry
4.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
0
Median 3Y
-65
Median 5Y
-96.1
Industry
3.5
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
88
vs Industry
37
Median 3Y
2.1
Median 5Y
4.1
Industry
4.4
More Details

Multiples Across Competitors

Competitors Multiples
Bloomage Biotechnology Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
9.9B CNY 1.9 300.4 170.5 170.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 35 448 623 -168 482 -204 590.9 -202 256.3
US
Abbvie Inc
NYSE:ABBV
325B USD 5.7 78.2 15 22.1
US
Amgen Inc
NASDAQ:AMGN
146.5B USD 4.3 24.7 13.5 22.3
US
Gilead Sciences Inc
NASDAQ:GILD
127.6B USD 4.4 21.4 9.4 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD 10.2 -114 24.2 25.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 987.4 -507.1 -552.2 -537.5
AU
CSL Ltd
ASX:CSL
117.1B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
64.3B USD 4.6 14.3 12.9 14.4
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.7 -63.2 -57
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
37.2B USD 15.8 -137.9 -615.3 -308.3
P/E Multiple
Earnings Growth PEG
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average P/E: 77.7
300.4
23%
13.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -168 482 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
24.7
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
21.4
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.1 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.3
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -137.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average EV/EBITDA: 37.5
170.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -204 590.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
13.5
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
7%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
18%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -552.2 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.9
14%
0.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -63.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -615.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Bloomage Biotechnology Corp Ltd
SSE:688363
Average EV/EBIT: 41.2
170.5
48%
3.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -202 256.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.1
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.3
31%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -537.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.4
13%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -57 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -308.3 N/A N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 255,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.